{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:11:28Z","timestamp":1792069888120,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,11,12]],"date-time":"2009-11-12T00:00:00Z","timestamp":1257984000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1741-7015-7-70","type":"journal-article","created":{"date-parts":[[2009,11,12]],"date-time":"2009-11-12T19:40:14Z","timestamp":1258054814000},"source":"Crossref","is-referenced-by-count":78,"title":["Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial"],"prefix":"10.1186","volume":"7","author":[{"given":"Camiel","family":"Verhamme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob J","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinus","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Baas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"de Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo N","family":"van Schaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,12]]},"reference":[{"key":"248_CR1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000472166","volume":"4","author":"E Nelis","year":"1996","unstructured":"Nelis E, Van Broeckhoven C, De Jonghe P, Lofgren A, Vandenberghe A, Latour P, Le Guern E, Brice A, Mostacciuolo ML, Schiavon F, Palau F, Bort S, Upadhyaya M, Rocchi M, Archidiacono N, Mandich P, Bellone E, Silander K, Savontaus ML, Navon R, Goldberg-Stern H, Estivill X, Volpini V, Friedl W, Gal A, et al: Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet. 1996, 4: 25-33.","journal-title":"Eur J Hum Genet"},{"key":"248_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/0022-510X(92)90282-P","volume":"107","author":"AA Gabre\u00ebls-Festen","year":"1992","unstructured":"Gabre\u00ebls-Festen AA, Joosten EM, Gabre\u00ebls FJ, Jennekens FG, Janssen-van Kempen TW: Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN type I). J Neurol Sci. 1992, 107: 145-154. 10.1016\/0022-510X(92)90282-P.","journal-title":"J Neurol Sci"},{"key":"248_CR3","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1093\/brain\/awf230","volume":"125","author":"A Robaglia-Schlupp","year":"2002","unstructured":"Robaglia-Schlupp A, Pizant J, Norreel JC, Passage E, Saberan-Djoneidi D, Ansaldi JL, Vinay L, Figarella-Branger D, Levy N, Clarac F, Cau P, Pellissier JF, Font\u00e9s M: PMP22 overexpression causes dysmyelination in mice. Brain. 2002, 125: 2213-2221. 10.1093\/brain\/awf230.","journal-title":"Brain"},{"key":"248_CR4","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1212\/WNL.50.4.1061","volume":"50","author":"A Garcia","year":"1998","unstructured":"Garcia A, Combarros O, Calleja J, Berciano J: Charcot-Marie-Tooth disease type 1A with 17p duplication in infancy and early childhood: a longitudinal clinical and electrophysiologic study. Neurology. 1998, 50: 1061-1067.","journal-title":"Neurology"},{"key":"248_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/(SICI)1097-4598(199601)19:1<74::AID-MUS10>3.0.CO;2-3","volume":"19","author":"JM Killian","year":"1996","unstructured":"Killian JM, Tiwari PS, Jacobson S, Jackson RD, Lupski JR: Longitudinal studies of the duplication form of Charcot-Marie-Tooth polyneuropathy. Muscle Nerve. 1996, 19: 74-78. 10.1002\/(SICI)1097-4598(199601)19:1<74::AID-MUS10>3.0.CO;2-3.","journal-title":"Muscle Nerve"},{"key":"248_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1212\/01.wnl.0000297553.36441.ce","volume":"70","author":"ME Shy","year":"2008","unstructured":"Shy ME, Chen L, Swan ER, Taube R, Krajewski KM, Herrmann D, Lewis RA, McDermott MP: Neuropathy progression in Charcot-Marie-Tooth disease type 1A. Neurology. 2008, 70: 378-383. 10.1212\/01.wnl.0000297553.36441.ce.","journal-title":"Neurology"},{"key":"248_CR7","volume-title":"Brain","author":"C Verhamme","year":"2009","unstructured":"Verhamme C, van Schaik IN, Koelman JH, De Haan RJ, de Visser M: The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study. Brain. 2009."},{"key":"248_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0960-8966(99)00114-5","volume":"10","author":"J Berciano","year":"2000","unstructured":"Berciano J, Garcia A, Calleja J, Combarros O: Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with Charcot-Marie-Tooth disease 1A duplication. Neuromuscul Disord. 2000, 10: 419-424. 10.1016\/S0960-8966(99)00114-5.","journal-title":"Neuromuscul Disord"},{"key":"248_CR9","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00415-004-0578-x","volume":"251","author":"C Verhamme","year":"2004","unstructured":"Verhamme C, van Schaik IN, Koelman JH, De Haan RJ, Vermeulen M, De Visser M: Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia. J Neurol. 2004, 251: 1491-1497. 10.1007\/s00415-004-0578-x.","journal-title":"J Neurol"},{"key":"248_CR10","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.nmd.2006.12.008","volume":"17","author":"F Kaya","year":"2007","unstructured":"Kaya F, Belin S, Bourgeois P, Micaleff J, Blin O, Fontes M: Ascorbic acid inhibits PMP22 expression by reducing cAMP levels. Neuromuscul Disord. 2007, 17: 248-253. 10.1016\/j.nmd.2006.12.008.","journal-title":"Neuromuscul Disord"},{"key":"248_CR11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nm1023","volume":"10","author":"E Passage","year":"2004","unstructured":"Passage E, Norreel JC, Noack-Fraissignes P, Sanguedolce V, Pizant J, Thirion X, Robaglia-Schlupp A, Pellissier JF, Fontes M: Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med. 2004, 10: 396-401. 10.1038\/nm1023.","journal-title":"Nat Med"},{"key":"248_CR12","volume-title":"Dietary reference intakes for vitamin C, Vitamin E, Selenium, and Carotenoids","author":"Food and Nutrition Board Institute of Medicine National Academy of Sciences","year":"2000","unstructured":"Food and Nutrition Board Institute of Medicine National Academy of Sciences: Dietary reference intakes for vitamin C, Vitamin E, Selenium, and Carotenoids. 2000, Washington DC: National Academy Press, http:\/\/www.nap.edu\/catalog.php?record_id=9810 ."},{"key":"248_CR13","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/mus.880171107","volume":"17","author":"JG van Dijk","year":"1994","unstructured":"van Dijk JG, Kamp van der WIM, van Hilten BJ, van Someren P: Influence of recording site on CMAP amplitude on its variation over a length of nerve. Muscle Nerve. 1994, 17: 1286-1292. 10.1002\/mus.880171107.","journal-title":"Muscle Nerve"},{"key":"248_CR14","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/(SICI)1097-4598(199606)19:6<689::AID-MUS1>3.0.CO;2-6","volume":"19","author":"AM Tjon-A-Tsien","year":"1996","unstructured":"Tjon-A-Tsien AM, Lemkes HH, Kamp-Huyts van der AJ, van Dijk JG: Large electrodes improve nerve conduction repeatability in controls as well as in patients with diabetic neuropathy. Muscle Nerve. 1996, 19: 689-695. 10.1002\/(SICI)1097-4598(199606)19:6<689::AID-MUS1>3.0.CO;2-6.","journal-title":"Muscle Nerve"},{"key":"248_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jnnp.54.3.244","volume":"54","author":"RJ van der Ploeg","year":"1991","unstructured":"Ploeg van der RJ, Fidler V, Oosterhuis HJ: Hand-held myometry: reference values. J Neurol Neurosurg Psychiatry. 1991, 54: 244-247. 10.1136\/jnnp.54.3.244.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"248_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.nmd.2007.09.006","volume":"18","author":"A Solari","year":"2008","unstructured":"Solari A, Laura M, Salsano E, Radice D, Pareyson D: Reliability of clinical outcome measures in Charcot-Marie-Tooth disease. Neuromuscul Disord. 2008, 18: 19-26. 10.1016\/j.nmd.2007.09.006.","journal-title":"Neuromuscul Disord"},{"key":"248_CR17","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1212\/WNL.54.4.943","volume":"54","author":"IS Merkies","year":"2000","unstructured":"Merkies IS, Schmitz PI, Mech\u00e9 van der FG, van Doorn PA: Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Neurology. 2000, 54: 943-949.","journal-title":"Neurology"},{"key":"248_CR18","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1212\/01.WNL.0000156517.00615.A3","volume":"64","author":"ME Shy","year":"2005","unstructured":"Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, Li J, Lewis RA, Reilly M: Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology. 2005, 64: 1209-1214.","journal-title":"Neurology"},{"key":"248_CR19","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1212\/01.wnl.0000295666.30948.9d","volume":"69","author":"N Weisscher","year":"2007","unstructured":"Weisscher N, Post B, De Haan RJ, Glas CAW, Speelman JD, Vermeulen M: The AMC Linear Disability Score in patients with newly diagnosed Parkinson disease. Neurology. 2007, 69: 2155-2161. 10.1212\/01.wnl.0000295666.30948.9d.","journal-title":"Neurology"},{"key":"248_CR20","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1136\/jnnp.72.5.596","volume":"72","author":"IS Merkies","year":"2002","unstructured":"Merkies IS, Schmitz PI, Meche van der FG, Samijn JP, van Doorn PA: Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies. J Neurol Neurosurg Psychiatry. 2002, 72: 596-601. 10.1136\/jnnp.72.5.596.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"248_CR21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/153944928500500102","volume":"5","author":"V Mathiowetz","year":"1985","unstructured":"Mathiowetz V, Weber K, Kashman N, Volland G: Adult norms for the nine hole peg test of finger dexterity. Occupational Therapy J Research. 1985, 5: 24-38. http:\/\/psycnet.apa.org\/?fa=main.doiLanding&uid=1986-05316-001 .","journal-title":"Occupational Therapy J Research"},{"key":"248_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clinph.2007.09.133","volume":"119","author":"JP van Dijk","year":"2008","unstructured":"van Dijk JP, Blok JH, Lapatki BG, van Schaik IN, Zwarts MJ, Stegeman DF: Motor unit number estimation using high-density surface electromyography. Clinical Neurophysiology. 2008, 119: 33-42. 10.1016\/j.clinph.2007.09.133.","journal-title":"Clinical Neurophysiology"},{"key":"248_CR23","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/bmj.323.7321.1123","volume":"323","author":"AJ Vickers","year":"2001","unstructured":"Vickers AJ, Altman DG: Statistics Notes: Analysing controlled trials with baseline and follow up measurements. BMJ. 2001, 323: 1123-1124. 10.1136\/bmj.323.7321.1123.","journal-title":"BMJ"},{"key":"248_CR24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1600-0536.1980.tb05592.x","volume":"6","author":"J Metz","year":"1980","unstructured":"Metz J, Hundertmark U, Pevny I: Vitamin C allergy of the delayed type. Contact Dermatitis. 1980, 6: 172-174. 10.1111\/j.1600-0536.1980.tb05592.x.","journal-title":"Contact Dermatitis"},{"key":"248_CR25","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1474-4422(09)70108-5","volume":"8","author":"J Burns","year":"2009","unstructured":"Burns J, Ouvrier RA, Yiu EM, Joseph PD, Kornberg AJ, Fahey MC, Ryan MM: Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial. Lancet Neurol. 2009, 8: 537-544. 10.1016\/S1474-4422(09)70108-5.","journal-title":"Lancet Neurol"},{"key":"248_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1600-0404.2008.01134.x","volume":"120","author":"C Toth","year":"2009","unstructured":"Toth C: Poor tolerability of high dose ascorbic acid in a population of genetically confirmed adult Charcot-Marie-Tooth 1A patients. Acta Neurol Scand. 2009, 120: 134-8. 10.1111\/j.1600-0404.2008.01134.x.","journal-title":"Acta Neurol Scand"},{"key":"248_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/hmg\/7.3.449","volume":"7","author":"C Huxley","year":"1998","unstructured":"Huxley C, Passage E, Robertson AM, Youl B, Huston S, Manson A, Sab\u00e9ran-Djoniedi D, Figarella-Branger D, Pellissier JF, Thomas PK, Font\u00e9s M: Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Genet. 1998, 7: 449-458. 10.1093\/hmg\/7.3.449.","journal-title":"Hum Mol Genet"},{"key":"248_CR28","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/ajcn\/34.7.1448","volume":"34","author":"E Ginter","year":"1981","unstructured":"Ginter E: Endogenous ascorbic acid synthesis and recommended dietary allowances for vitamin C. Am J Clin Nutr. 1981, 34: 1448-1451.","journal-title":"Am J Clin Nutr"},{"key":"248_CR29","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.nmd.2006.03.008","volume":"16","author":"MM Reilly","year":"2006","unstructured":"Reilly MM, de JP, Pareyson D: 136th ENMC International Workshop: Charcot-Marie-Tooth disease type 1A (CMT1A) 8-10 April 2005, Naarden, The Netherlands. Neuromuscul Disord. 2006, 16: 396-402. 10.1016\/j.nmd.2006.03.008.","journal-title":"Neuromuscul Disord"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-7-70.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1741-7015-7-70\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1741-7015-7-70","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:19:38Z","timestamp":1558642778000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/1741-7015-7-70"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,12]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["248"],"URL":"https:\/\/doi.org\/10.1186\/1741-7015-7-70","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,12]]},"article-number":"70"}}